Evidence map›Paper›PMID 30504836›Full record

ArticleNature communications2018

Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6

Seo-Hyun Choi, A-Ram Kim, Jae-Kyung Nam, Jin-Mo Kim, Jee-Youn Kim, Haeng Ran Seo, Hae-June Lee, Jaeho Cho, Yoon-Jin Lee

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 3 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Seo-Hyun ChoiDivision of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 139-706, Korea.
A-Ram KimDivision of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 139-706, Korea.
Jae-Kyung NamDivision of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 139-706, Korea.
Jin-Mo KimDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, 120-752, Korea.
Jee-Youn KimDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, 120-752, Korea.
Haeng Ran SeoCancer Biology Research Laboratory, Institute Pasteur Korea, Gyeonggi-do, 13488, Korea.
Hae-June LeeDivision of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 139-706, Korea.
Jaeho ChoDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, 120-752, Korea.ORCID http://orcid.org/0000-0001-9966-5157
Yoon-Jin LeeDivision of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 139-706, Korea. yjlee8@kirams.re.kr.ORCID http://orcid.org/0000-0002-3110-0384
Korea Institute of Radiological and Medical Sciences · KRYonsei University · KRInstitut Pasteur Korea · KRMemorial Sloan Kettering Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It remains controversial whether targeting tumour vasculature can improve radiotherapeutic efficacy. We report that radiation-induced endothelial-to-mesenchymal transition (EndMT) leads to tumour vasculature with abnormal SMA

Indexed as

AnimalsBenzylaminesCell Line, TumorCell TransdifferentiationCyclamsEndothelial CellsEpithelial-Mesenchymal TransitionFemaleHeterocyclic CompoundsHumansHyaluronan ReceptorsImmunohistochemistryMacrophagesMaleMiceMice, Inbred BALB CBenzylaminesCD44v6 antigenCXCR4 protein, mouseCyclamsHeterocyclic CompoundsHyaluronan ReceptorsplerixaforReceptors, CXCR4Receptor, Transforming Growth Factor-beta Type II

Identifiers

PMID30504836
PMCPMC6269447
OpenAlexW2902092124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.